Upgrade to SI Premium - Free Trial

Alnylam Pharmaceuticals (ALNY) PT Raised to $128 at BMO Capital

May 1, 2019 12:59 PM
BMO Capital analyst Do Kim raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $128.00 (from $126.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles